drenogrip
belfar ltda - dipirona, cafeÍna, maleato de clorfeniramina - produtos para terapia sintomatica da gripe
norxacin
laboratÓrio globo sa - norfloxacino - antibioticos sistemicos simples
osteotec
adium s.a. - ibandronato de sódio monoidratado - supressores da reabsorcao ossea
pergoveris
merck s/a - alfafolitropina, alfalutropina - hormonio gonadotrofico
respiratus
sanofi medley farmacÊutica ltda. - hedera helix l. - expectorantes; fitoterapico simples
simponi
janssen-cilag farmacÊutica ltda - golimumabe - antinflamatorios
visudyne
novartis biociencias s.a - verteporfina - outros medicamentos com acao no aparelho visual
bromidrato de galantamina
fundaÇÃo para o remÉdio popular - furp - bromidrato de galantamina - outros produtos que atuam sobre o sistema nervoso
skyrizi
abbvie deutschland gmbh & co. kg - risankizumab - psoriasis; arthritis, psoriatic - imunossupressores - plaque psoriasisskyrizi is indicated for the treatment of moderate to severe plaque psoriasis in adults who are candidates for systemic therapy. psoriatic arthritisskyrizi, alone or in combination with methotrexate (mtx), is indicated for the treatment of active psoriatic arthritis in adults who have had an inadequate response or who have been intolerant to one or more disease-modifying antirheumatic drugs (dmards). crohn's diseaseskyrizi is indicated for the treatment of adult patients with moderately to severely active crohn's disease who have had an inadequate response to, lost response to, or were intolerant to conventional therapy or a biologic therapy.
uptravi
janssen-cilag farmacÊutica ltda - selexipague - anti-hipertensivos para hipertensÃo arterial pulmonar